Cargando…
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project
Fractional dose is an important strategy to increase access to vaccines. This study evaluated the effectiveness, safety, and immunogenicity of half dose of ChAdOx1 nCoV-19 vaccine. A non-inferiority non-randomized controlled trial compared a half dose of ChAdOx1 nCoV-19 with the full dose, with an i...
Autores principales: | Valim, Valéria, Martins-Filho, Olindo Assis, Gouvea, Maria da Penha Gomes, Camacho, Luiz Antônio Bastos, Villela, Daniel Antunes Maciel, de Lima, Sheila Maria Barbosa, Azevedo, Adriana Souza, Neto, Lauro Ferreira Pinto, Domingues, Carla Magda Allan Santos, de Medeiros Junior, Nésio Fernandes, Moulaz, Isac Ribeiro, Dias, Laiza Hombre, Miyamoto, Samira Tatiyama, Teixeira-Carvalho, Andréa, Mill, José Geraldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464812/ https://www.ncbi.nlm.nih.gov/pubmed/36105814 http://dx.doi.org/10.3389/fimmu.2022.966416 |
Ejemplares similares
-
EFETIVIDADE, IMUNOGENICIDADE E SEGURANÇA DA MEIA DOSE DA VACINA CHADOX1 NCOV-19 CONTRA SARS-COV2 (PROJETO VIANA)
por: Valim, Valéria, et al.
Publicado: (2022) -
Half dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases
por: Galvão-Lima, Leonardo J., et al.
Publicado: (2023) -
Adult-onset Still's disease after ChAdOx1 nCoV-19 vaccine: a possible association
por: Albertino, Laíssa Fiorotti, et al.
Publicado: (2022) -
REATOGENICIDADE COM MEIA DOSE DA VACINA CHADOX1 NCOV-19 (AZD1222)
por: Gouvea, Maria da Penha Gomes, et al.
Publicado: (2022) -
Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021)